News

A new scoring tool that helps to transparently prioritize which countries are in greatest need of COVID-19 vaccines, has been developed by a UCL-led team of researchers.

Rsearchers have unveiled a new lab technique they say represents a “paradigm shift” in how pharmaceutical laboratories test and produce new protein-based drugs, such as therapeutic monoclonal antibodies being developed to treat a variety of diseases, from cancers to infectious diseases.

Tick saliva has been found to inhibit the skin's defense function, thereby increasing the risk of diseases such as tick-borne encephalitis (TBE) or Lyme disease.

Researchers have determined the structure of the filaments that allow bacteria such as E.coli to move in atomic detail.

A large international study has confirmed the findings of a previous U.S. study that linked COVID-19 vaccination with an average increase in menstrual cycle length of less than one day.

The first large, real-world study of the effectiveness of mRNA COVID-19 vaccines during pregnancy found these vaccines, especially two initial doses followed by a booster, are effective in protecting against serious disease in expectant mothers whether the shots are administered before or during pregnancy.

Researchers have underpinned the molecular mechanism behind the immune system's "off switch", contributing to global efforts to design immune-boosting treatments.

Combining microbiology with engineering technologies, this novel 3D model uses a single microfluidic chip to study the complicated processes that take place in malaria-infected placenta as well as other placenta-related diseases and pathologies.

Creating a mutation that inhibits how the bacterial pathogen Neisseria gonorrhoeae causes gonorrhea, a common sexually transmitted infection, could offer a new way to prevent and treat the disease, according to researchers in the Institute for Biomedical Sciences at Georgia State University.

New research indicates that viruses are able to sense their environment to decide when to multiply and kill the host cell, adding a new dimension to viral-host interactions.